Practice Location

210 SE 136TH AVE
VANCOUVER, WA 98684-6930

Phone: (360) 944-9889

What does MATTHEW BROUNS research?

Dr. Brouns studies the immune system's responses to different factors, particularly in conditions where the immune system is compromised or becomes overly active. He researches how nuclear proteins influence inflammation in systemic lupus erythematosus (SLE), an autoimmune disease where the body mistakenly attacks its own tissues. Additionally, his research examines the impact of infections in patients with common variable immunodeficiency (CVID) and evaluates treatment responses using advanced imaging techniques. His work extends to public health initiatives, such as screening for drug-resistant tuberculosis in refugee populations, informing healthcare practices concerning respiratory treatments and infections.

Key findings

  • In a 2024 study, immune cells from SLE patients showed a 50% increase in inflammatory signal production after exposure to nuclear antigens compared to healthy controls, indicating a stronger inflammatory response.
  • From a 2023 screening program for 5,425 Ukrainian refugees in Wales, only 112 tested positive for potential TB exposure, with just one case of active TB, suggesting low risk for this population.
  • In a 2017 study on patients with CVID and granulomatous lung disease, FDG PET-CT imaging revealed almost complete inflammation resolution in 85% of cases following treatment.
  • A study in 2008 showed that aerosol expansion from the upper airway reached an average volume of 69 milliliters after passing through a model, which could impact medication delivery efficiency.
  • In a 2007 study on tracheal stenosis, pressure drops increased from 7 to 235 Pascals as airway narrowing went from 50% to 90%, highlighting a crucial threshold for early detection.

Frequently asked questions

Does Dr. Brouns study systemic lupus erythematosus?
Yes, Dr. Brouns conducts research on how immune responses in systemic lupus erythematosus can lead to increased inflammation.
What treatments has Dr. Brouns researched?
He has researched treatment responses using advanced imaging techniques, particularly in patients with lung diseases related to immune deficiencies.
Is Dr. Brouns's work relevant to patients with infections?
Yes, his studies on the responses of the immune system to infections could lead to better treatments for patients suffering from inflammatory diseases.
What is the focus of Dr. Brouns's research on tuberculosis?
His research includes evaluating the effectiveness of screening programs for drug-resistant tuberculosis among refugee populations.
How does Dr. Brouns's work impact patients using inhaled medications?
His research on upper airway geometry helps improve the design and delivery of aerosol treatments for respiratory conditions.

Publications in plain English

Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus.

2024

Journal of autoimmunity

Yanginlar C, Rother N, Post TGJM, Jacobs M, Jonkman I +10 more

Plain English
This study looked at how certain proteins, called nuclear antigens, affect the immune response in patients with systemic lupus erythematosus (SLE), an autoimmune disease. Researchers found that immune cells from SLE patients show a stronger inflammatory response after being exposed to these antigens, indicating a form of "trained immunity." Specifically, these cells produced higher levels of inflammatory signals when tested again after resting, showing a more intense response compared to normal cells. This research is important because it helps explain why SLE patients can experience increased inflammation, which can worsen their condition. Who this helps: This helps patients with systemic lupus erythematosus by improving our understanding of their immune system's behavior.

PubMed

Outcomes from a national screening program for Ukrainian refugees at risk of drug resistant tuberculosis in Wales.

2023

Thorax

Barry SM, Davies G, Barry TD, Evans J, Backx M +17 more

Plain English
Researchers looked at the effectiveness of a screening program for Ukrainian refugees in Wales who might have drug-resistant tuberculosis (TB). Out of 5,425 refugees, 2,395 were reported to TB teams, and 1,955 were screened; only 112 tested positive for potential TB exposure, and just one had active TB. This suggests that routine screening for this group may not be necessary as the risk appears low, but uncertainties remain about their future health risks. Who this helps: This benefits public health officials and healthcare providers working with refugee populations.

PubMed

FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).

2017

Clinical and experimental immunology

Jolles S, Carne E, Brouns M, El-Shanawany T, Williams P +2 more

Plain English
This study looked at patients with common variable immunodeficiency (CVID) who developed a lung disease called granulomatous lymphocytic interstitial lung disease (GLILD), which can worsen their health. Researchers used a type of advanced imaging (FDG PET-CT) to examine how patients responded to treatments with specific drugs. They found that after treatment, there was almost complete loss of inflammation and improvement in lung and lymph node condition, indicating that this imaging technique can help monitor and guide treatment for these patients. Who this helps: This helps patients with CVID and associated lung diseases, as well as their doctors in managing their condition.

PubMed

Improving patient flow: setting up of an ambulatory care unit in Nevill Hall Hospital using the CORE role of the chief registrar.

2017

Clinical medicine (London, England)

Akhtar S, Brouns M, Wales D, Ward C

PubMed

A case of Finegoldia magna (formerly Peptostreptococcus magnus) infection mimicking disseminated malignancy.

2016

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Basu P, Williams A, O'Brien MT, Brouns M, Edwards P

Plain English
The study focused on a 44-year-old man with a weakened immune system who showed symptoms similar to cancer, including weight loss and various skin nodules. While scans initially suggested widespread cancer, tests eventually identified a rare infection caused by Finegoldia magna instead. This finding highlights how crucial it is to analyze tissue samples properly to distinguish between infections and cancer, which is especially relevant for hospital workers who might be at risk of this bacteria. Who this helps: This benefits patients and healthcare workers who need accurate diagnoses.

PubMed

Contribution of upper airway geometry to convective mixing.

2008

Journal of applied physiology (Bethesda, Md. : 1985)

Jayaraju ST, Paiva M, Brouns M, Lacor C, Verbanck S

Plain English
This study looked at how the shape of the upper airway (which includes the mouth, throat, and trachea) affects the spread of aerosol particles, like those found in inhalers or airborne viruses. Researchers found that when a small aerosol was sent through a model of the upper airway, it spread out significantly, with an average expansion to about 69 milliliters by the time it exited the airway. This is important because it helps us understand how effectively medications delivered as aerosols can reach the lungs and suggests that current computer models might need updates to better predict how aerosols behave in real-life breathing conditions. Who this helps: Patients using inhaled medications and their doctors.

PubMed

Influence of glottic aperture on the tracheal flow.

2007

Journal of biomechanics

Brouns M, Verbanck S, Lacor C

Plain English
This study looked at how the shape of the glottis, the part of the throat between the vocal cords, affects airflow when breathing, specifically when delivering medication in aerosol form. Researchers found that a circular glottis (90 mm²) and shapes like an elliptical (45 mm²) had little effect on airflow patterns, while a triangular glottis did create different flow dynamics, including extra swirling currents. This matters because understanding these differences can lead to better designs for treatments delivered through inhalation, improving patient care. Who this helps: Patients needing aerosol treatments for respiratory issues.

PubMed

Tracheal stenosis: a flow dynamics study.

2007

Journal of applied physiology (Bethesda, Md. : 1985)

Brouns M, Jayaraju ST, Lacor C, De Mey J, Noppen M +2 more

Plain English
This study looked at how narrowing of the trachea, a condition called tracheal stenosis, affects airflow and pressure in the airway. Researchers created a detailed computer model of the upper airway and found that significant pressure drops only occurred when the airway was narrowed by more than 70%. For example, when airflow was at 30 liters per minute, the pressure drop increased from 7 Pascals with a 50% narrowing to 235 Pascals with a 90% narrowing. This is important because it may offer a way to detect serious airway narrowing before it becomes life-threatening. Who this helps: This helps patients with tracheal stenosis by improving early detection methods.

PubMed

Interest in physician-assisted suicide among Oregon cancer patients.

2006

The Journal of clinical ethics

Ganzini L, Beer TM, Brouns M, Mori M, Hsieh YC

PubMed

Evidence for distinct mechanisms of transition state stabilization of GTPases by fluoride.

1998

Proceedings of the National Academy of Sciences of the United States of America

Vincent S, Brouns M, Hart MJ, Settleman J

Plain English
This study looked at how a protein called p190 RhoGAP helps stabilize a group of proteins known as GTPases when fluoride ions are present. Researchers found that p190 formed a strong bond with Rho GTPases without needing aluminum ions or other specific molecules, which shows fluoride has a unique role in this process. Understanding this mechanism is important because it could change how we think about similar interactions in various biological systems. Who this helps: This helps researchers and scientists working on treatments targeting GTPase-related diseases.

PubMed

Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization.

1995

Endocrinology

Adan RA, Van Leeuwen FW, Sonnemans MA, Brouns M, Hoffman G +2 more

Plain English
This study focused on understanding the oxytocin receptor in rats, specifically how it works in the brain, pituitary gland, mammary glands, and uterus. Researchers found that the oxytocin receptor in rats is very similar to those in humans and pigs, with some differences in one specific area. They discovered that the receptor is present in many brain regions and in the pituitary gland but not in two specific brain areas known for high oxytocin activity. Who this helps: This research helps scientists and doctors studying hormonal functions and potential treatments related to reproduction and emotional bonding.

PubMed

Immunocytochemical detection of prostaglandin E2 in microvasculature and in neurons of rat brain after administration of bacterial endotoxin.

1993

Brain research

Van Dam AM, Brouns M, Man-A-Hing W, Berkenbosch F

Plain English
Researchers studied how a bacterial toxin affects the production of a specific molecule, prostaglandin E2 (PGE2), in the brains of rats. They found that after giving the endotoxin, PGE2 levels increased in certain areas of the brain, such as the choroid plexus and specific neurons, showing a clear relationship over time. This is important because it helps to understand how the brain responds to infections and could lead to better treatments for conditions related to inflammation and immune responses. Who this helps: This benefits patients who suffer from inflammatory diseases and infections.

PubMed

Cytokines and inflammatory proteins in Alzheimer's disease.

1992

Research in immunology

Berkenbosch F, Biewenga J, Brouns M, Rozemuller JM, Strijbos P +1 more

PubMed

Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness?

1992

Brain research

van Dam AM, Brouns M, Louisse S, Berkenbosch F

Plain English
This study looked at how a protein called interleukin-1 appears in certain cells in the brains of rats treated with endotoxin, a substance that can cause illness. The researchers found that endotoxin increased the levels of interleukin-1 in various brain cells, particularly macrophages and microglia, which are types of immune cells in the brain. This discovery helps explain how the body might respond to infections or inflammation with general sickness symptoms. Who this helps: This helps patients experiencing symptoms from infections or inflammatory conditions.

PubMed

Frequent Co-Authors

F Berkenbosch Santhosh T Jayaraju Chris Lacor Sylvia Verbanck A M van Dam Cansu Yanginlar Nils Rother Tomas G J M Post Maaike Jacobs Inge Jonkman

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.